CA2866837A1 - Polypeptides and their use - Google Patents

Polypeptides and their use Download PDF

Info

Publication number
CA2866837A1
CA2866837A1 CA2866837A CA2866837A CA2866837A1 CA 2866837 A1 CA2866837 A1 CA 2866837A1 CA 2866837 A CA2866837 A CA 2866837A CA 2866837 A CA2866837 A CA 2866837A CA 2866837 A1 CA2866837 A1 CA 2866837A1
Authority
CA
Canada
Prior art keywords
polypeptide
malassezia
product
infection
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2866837A
Other languages
English (en)
French (fr)
Inventor
Deborah O'neil
Derry Mercer
Colin Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NovaBiotics Ltd
Original Assignee
NovaBiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NovaBiotics Ltd filed Critical NovaBiotics Ltd
Publication of CA2866837A1 publication Critical patent/CA2866837A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Polyamides (AREA)
CA2866837A 2012-03-14 2013-03-14 Polypeptides and their use Abandoned CA2866837A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1204457.4 2012-03-14
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use
US201261620833P 2012-04-05 2012-04-05
US61/620,833 2012-04-05
PCT/GB2013/000112 WO2013136040A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Publications (1)

Publication Number Publication Date
CA2866837A1 true CA2866837A1 (en) 2013-09-19

Family

ID=46026493

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2866837A Abandoned CA2866837A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Country Status (17)

Country Link
US (1) US20140155321A1 (enExample)
EP (1) EP2825261A1 (enExample)
JP (1) JP2015516943A (enExample)
KR (1) KR20140138940A (enExample)
CN (1) CN104428036A (enExample)
AU (1) AU2013234122A1 (enExample)
CA (1) CA2866837A1 (enExample)
CL (1) CL2014002397A1 (enExample)
GB (1) GB201204457D0 (enExample)
HK (1) HK1201050A1 (enExample)
IL (1) IL234646A0 (enExample)
MX (1) MX2014010996A (enExample)
NZ (1) NZ700467A (enExample)
RU (1) RU2014139857A (enExample)
SG (1) SG11201405539QA (enExample)
WO (1) WO2013136040A1 (enExample)
ZA (1) ZA201407276B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2981037C (en) * 2015-04-03 2019-04-30 Elc Management Llc Hair treatment compositions comprising hydrolyzed wheat protein and polyquaternium-6
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
WO2017047299A1 (ja) * 2015-09-15 2017-03-23 富士フイルム株式会社 注射用液剤組成物
CN109700834A (zh) * 2019-01-18 2019-05-03 上海市农业科学院 一种蛹虫草固体发酵物及其抗菌用途
AR122485A1 (es) 2020-06-04 2022-09-14 Syngenta Crop Protection Ag Composiciones fungicidas
CN115381928B (zh) * 2022-10-27 2022-12-27 山东中医药大学附属医院 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用
JP2024082709A (ja) * 2022-12-09 2024-06-20 日本メナード化粧品株式会社 抗菌剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1927597T3 (en) * 2004-08-18 2017-02-13 Novabiotics Ltd ANTIBACTERIAL PEPTIDES
GB0611115D0 (en) * 2006-06-06 2006-07-19 Novabiotics Ltd Compounds and their use
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702022D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
EP2224901A1 (en) * 2007-12-21 2010-09-08 Basf Se Anti-dandruff compositions containing peptides

Also Published As

Publication number Publication date
RU2014139857A (ru) 2016-05-10
HK1201050A1 (en) 2015-08-21
EP2825261A1 (en) 2015-01-21
CL2014002397A1 (es) 2015-02-27
IL234646A0 (en) 2014-11-30
US20140155321A1 (en) 2014-06-05
WO2013136040A1 (en) 2013-09-19
CN104428036A (zh) 2015-03-18
KR20140138940A (ko) 2014-12-04
AU2013234122A1 (en) 2014-10-16
SG11201405539QA (en) 2014-10-30
GB201204457D0 (en) 2012-04-25
JP2015516943A (ja) 2015-06-18
NZ700467A (en) 2016-08-26
ZA201407276B (en) 2015-06-24
MX2014010996A (es) 2014-10-13

Similar Documents

Publication Publication Date Title
JP6653342B2 (ja) 真菌感染症の治療用の局所用オイル組成物
US20140155321A1 (en) Polypeptides and Their Use
US20190142800A1 (en) Synergistic antifungal compositions and methods thereof
ES2729237T3 (es) Lipopéptidos antimicrobianos cortos
US8076484B2 (en) Modified green tea polyphenol formulations
US9248160B1 (en) Post-procedure skin care systems, compositions, and methods of use thereof
JP5882260B2 (ja) ペプチドおよびその使用
CN110538313A (zh) 一种广谱抗马拉色菌的天然产物组合物及应用
US20130131121A1 (en) Anti-viral agent
JP5832302B2 (ja) ケラチンへの局所薬剤デリバリーにおける表面活性タンパク質の組成物、使用及び使用方法
CN103957907A (zh) 抗真菌剂
KR20110017599A (ko) 폴리페놀 화합물을 함유하는 모공 축소용 조성물
KR101449129B1 (ko) Ａｂｈ 항원의 발현을 조절하는 물질을 포함하는 조성물
BR112013027489B1 (pt) uso cosmético de e-polilisina (épsilon-polilisina)
KR20070107806A (ko) 세르타코나졸, 및 하이드로코르티손 및/또는 항박테리아퀴놀린 화합물을 포함하는 항진균 조성물
JP2009167139A (ja) 外用組成物
KR102300945B1 (ko) 폴리글리세린-3을 함유하는 항균 또는 보존용 조성물
KR20140119452A (ko) 멘톨 및 그 유사물질을 함유하는 피부 트러블 개선용 조성물
JP2022164911A (ja) 糖化ストレス抑制剤
KR20110086466A (ko) 신규한 항생제 조성물 및 그람양성균의 치료 방법
KR101733189B1 (ko) 손톱 또는 발톱 성장 촉진용 조성물
KR20250043943A (ko) 말라세지아 패치더마티스에 대한 항균 조성물
HK40060583A (en) Anti-fungal agent
WO2020209215A1 (ja) 抗真菌剤
HK1138773A (en) Anti-viral agent

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180314